Avadel Pharmaceuticals's total assets for Q3 2024 were $158.25M, an increase of 0.46% from the previous quarter. AVDL total liabilities were $83.59M for the fiscal quarter, a -4.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.